Cite
HARVARD Citation
Vogelmeier, C. et al. (2020). Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators: an analysis of the EMAX randomised controlled trial. Therapeutic advances in respiratory disease. p. . [Online].